Submission Details
| 510(k) Number | K183120 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 09, 2018 |
| Decision Date | August 06, 2019 |
| Days to Decision | 270 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K183120 is an FDA 510(k) clearance for the EmboCube Embolization Gelatin, a Device, Vascular, For Promoting Embolization (Class II — Special Controls, product code KRD), submitted by Biosphere Medical, S.A. (Roissy-En-France, FR). The FDA issued a Cleared decision on August 6, 2019, 270 days after receiving the submission on November 9, 2018. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.3300.
| 510(k) Number | K183120 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 09, 2018 |
| Decision Date | August 06, 2019 |
| Days to Decision | 270 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | KRD — Device, Vascular, For Promoting Embolization |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.3300 |